Health Catalyst Reports First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Health Catalyst Inc. (HCAT) PT Lowered to $42 at Goldman Sachs
May 11, 2022 6:55 AM EDTGoldman Sachs analyst Cindy Motz lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $42.00 (from $49.00) while maintaining a Buy rating.
The analyst commented, "Health Catalyst posted a good earnings report with revenue growth in the range of 24% year over year, and surprising the market with positive... More
